Nicole Baetz
Scientific Resources
Solubility of ADCs: Influencing Factors and Optimization Tips
The solubility of ADCs is a critical factor not only for clinical efficacy and safety, but also for manufacturability. Here, we will discuss the factors that affect the solubility of ADCs and how to optimize their solubility.
Therapeutic mAbs
Using Antibody Drug Conjugates (ADC) for Therapy
Delivering chemotherapy with the specificity of monoclonal antibodies!
Therapeutic mAbs, Analytics, News
Host Cell Protein Analysis for Biologics Development
What are host cell proteins in biologic drugs?
Therapeutic mAbs, News, Scientific Resources
Therapeutic Antibodies as Immune Checkpoint Inhibitors
Immunotherapy and Immune checkpoint inhibitors
Bispecific antibodies, Therapeutic mAbs
Bispecific Antibodies: The Next Generation of Antibody Therapeutics (Part 2)
Bispecific Antibodies: Therapeutic applications and clinical pipeline. Bispecific antibodies have triggered considerable interest in the medical field and in the pharmaceutical industry over the last few years.
Therapeutic mAbs, Biosimilars
Therapeutic Antibodies to Treat Cancer Targeting CD20
Therapeutic antibodies for cancer targeting CD20 have been successfully used in immunotherapies to treat B-cell malignancies and auto-immune diseases.
Therapeutic mAbs, Biosimilars
Reference Drugs (RMPs/RLDs) and Reference Standards: Exploring the Difference
It is important to first establish a reference standard while assessing biosimilarity between a biosimilar product and the reference product.
Bispecific antibodies, News
Bispecific Antibodies: The Next Generation of Antibody Therapeutics (Part 1)
Discovery of antibodies, also known as immunoglobulins, paved the way for the evolution of protein-based therapeutic molecules (biologics).
